☰

Jeevan R. Kunta, Ph.D. - Publications

Affiliations: 
2002 Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Area:
Pharmacy
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Dallas S, Salphati L, Gomez-Zepeda D, Wanek T, Chen L, Chu X, Kunta J, Mezler M, Menet MC, Chasseigneaux S, Decleves X, Langer O, Pierre E, DiLoreto K, Hoft C, et al. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model. Molecular Pharmacology. PMID 26893303 DOI: 10.1124/mol.115.102079  0.337
2014 Salphati L, Chu X, Chen L, Prasad B, Dallas S, Evers R, Mamaril-Fishman D, Geier EG, Kehler J, Kunta J, Mezler M, Laplanche L, Pang J, Rode A, Soars MG, et al. Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 42: 1301-13. PMID 24855184 DOI: 10.1124/Dmd.114.057976  0.314
2014 Alluri RV, Ward P, Kunta JR, Ferslew BC, Thakker DR, Dallas S. In vitro characterization of intestinal and hepatic transporters: MRP2 Methods in Pharmacology and Toxicology. 369-404. DOI: 10.1007/978-1-62703-742-6-22  0.457
2006 Rautio J, Humphreys JE, Webster LO, Balakrishnan A, Keogh JP, Kunta JR, Serabjit-Singh CJ, Polli JW. In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 786-92. PMID 16455806 DOI: 10.1124/Dmd.105.008615  0.432
2006 Keogh JP, Kunta JR. Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoprotein. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 27: 543-54. PMID 16406207 DOI: 10.1016/J.Ejps.2005.11.011  0.453
2004 Kunta JR, Lee SH, Perry BA, Lee YH, Sinko PJ. Differentiation of gut and hepatic first-pass loss of verapamil in intestinal and vascular access-ported (IVAP) rabbits. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 32: 1293-8. PMID 15304428 DOI: 10.1124/Dmd.104.000752  0.682
2004 Sinko PJ, Kunta JR, Usansky HH, Perry BA. Differentiation of gut and hepatic first pass metabolism and secretion of saquinavir in ported rabbits. The Journal of Pharmacology and Experimental Therapeutics. 310: 359-66. PMID 15004217 DOI: 10.1124/Jpet.103.064394  0.496
2004 Kunta JR, Sinko PJ. Intestinal drug transporters: in vivo function and clinical importance. Current Drug Metabolism. 5: 109-24. PMID 14965254 DOI: 10.2174/1389200043489144  0.638
2001 Kunta JR, Perry BA, Sutyak JP, Sinko PJ. Development of a novel intestinal and vascular access port (IVAP) rabbit model to study regiospecific oral absorption pharmacokinetics. Comparative Medicine. 51: 349-56. PMID 11924794  0.667
2001 Lee YH, Perry BA, Lee HS, Kunta JR, Sutyak JP, Sinko PJ. Differentiation of gut and hepatic first-pass effect of drugs: 1. Studies of verapamil in ported dogs. Pharmaceutical Research. 18: 1721-8. PMID 11785692 DOI: 10.1023/A:1013374630274  0.654
2000 Kunta J, Yan J, Makhey VD, Sinko PJ. Active efflux kinetics of etoposide from rabbit small intestine and colon Biopharmaceutics and Drug Disposition. 21: 83-93. PMID 11113881 DOI: 10.1002/1099-081X(200004)21:3<83::Aid-Bdd220>3.0.Co;2-J  0.597
Show low-probability matches.